trial

Mindfulness Group-based Intervention for Early Psychosis: A Pilot Study

NCTId NCT02342210
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 21 (actual)
Sponsored by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Primary completion 2016-04
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
21 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2015-05
Primary completion
2016-04
Eligibility
ALL · 18 Years · 30 Years

Interventions & indications

Drugs
Mindfulness Ambassador Council for Early Psychosis (MAC-EP)

Sponsors

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sLead Sponsor
University of Western Ontario, CanadaCollaborator
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sCollaborator
Mindfulness Without BordersCollaborator

Investigators

1
Arlene MacDougall, M.Sc., M.D.Principal Investigator

Sites

0 total

Facts & assertions

4 sourced
Enrollment
21
Phase
NA
Primary Completion Date
2016-04
Status
COMPLETED
relationships
The graph out of here
drug
Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
drug
lead_sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
company
collaborator
University of Western Ontario, Canada
company
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
company
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
investigator
Arlene MacDougall, M.Sc., M.D.
person